Immunophotonics Inc.
St. Louis, MO
- UEI
- TKECQDEX4LA9
- CAGE
- 61P32
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4340 Duncan Ave Suite 212, St. Louis, MO 63110, USA
- Website
- immunophotonics.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma… | National Cancer Institute (NIH) | $5,200,000 |
Quick answers
Is Immunophotonics Inc. registered in SAM.gov?
Yes. Immunophotonics Inc.'s SAM.gov registration is active through June 29, 2027.
What is Immunophotonics Inc.'s most recent federal award?
Immunophotonics Inc.'s most recent federal grant award is Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma… (R44CA257683), from National Cancer Institute (NIH), on August 16, 2021.
On GovTribe
See Immunophotonics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors